Intravitreal Injection of Bevacizumab (Avastin) as Adjunctive Treatment of Proliferative Diabetic Retinopathy
- 26 May 2006
- journal article
- case report
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 142 (4), 685-688
- https://doi.org/10.1016/j.ajo.2006.04.058
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY VITREOUS HEMORRHAGERetina, 2006
- Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic IndividualsOphthalmology, 2006
- Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular DegenerationOphthalmic Surgery, Lasers and Imaging Retina, 2005
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal NeovascularizationThe Journal of Experimental Medicine, 2003
- Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein OcclusionAmerican Journal of Ophthalmology, 2002